Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC INNOVATION FUND · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

HDFC INNOVATION FUNDHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseHDFCHDFC
NAV₹12.2950₹23.6750
NAV date20 Nov 202620 Nov 2026
History1.3 years3.1 years
Expense ratio1.0%1.1%
StarsNot rated★★★★★
Growth Score—94.50

Returns

HDFC INNOVATION FUNDHDFC Pharma and Healthcare Fund
1 month+7.55%+12.97%
3 months+2.10%+7.13%
6 months+18.10%+17.84%
YTD+19.71%+33.73%
1 year+16.72%+32.20%
3 years (CAGR)—+30.70%
5 years (CAGR)——
10 years (CAGR)——
Since launch+16.51%+31.83%

Risk

HDFC INNOVATION FUNDHDFC Pharma and Healthcare Fund
Volatility—15.8%
Downside volatility—8.5%
Sharpe—1.53
Sortino—2.86
Calmar—2.06
Return / risk—1.95
Deepest fall−12.30%−14.91%
Days to recover36126
Below its high−0.49%+0.00%

Against benchmark

HDFC INNOVATION FUNDHDFC Pharma and Healthcare Fund
Alpha—+7.54%
Beta—0.97
R²—85.0%
Up capture—108.9%
Down capture—71.0%
Tracking error—6.1%
Information ratio—1.17
Treynor—0.24

Consistency

HDFC INNOVATION FUNDHDFC Pharma and Healthcare Fund
Best 1-year+22.84%+67.01%
Middle 1-year+16.25%+23.25%
Worst 1-year+5.60%+1.71%
1-year periods with a loss0.0%0.0%
Middle 3-year—+30.22%
Positive months—72.2%
Best day+2.84%+3.18%
Worst day−2.91%−3.61%
Worst 5% day−1.46%−1.51%
Positive days54.2%58.3%
NAVs a year247247

SIP of ₹10,000 a month

HDFC INNOVATION FUNDHDFC Pharma and Healthcare Fund
5-year XIRR——
5-year value——
3-year XIRR—+27.71%
1-year XIRR+28.25%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth